Health Care - As introduced, enacts the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," which prohibits individuals, including professional providers of health care and veterinary medicine, from administering any vaccine or other injectable solution that contains an mRNA vaccine or vaccine material. - Amends TCA Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68.

HB 1852, the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," would prohibit healthcare and veterinary providers from administering any vaccine or injectable solution containing mRNA technology. If enacted, it would directly affect medical professionals, clinics, and veterinary practices across Tennessee by banning the use of all mRNA-based vaccines and treatments. The bill amends multiple Tennessee Code titles to implement this prohibition, targeting mRNA-containing products specifically. It does not address other vaccine types or non-injectable treatments. The bill is currently pending in committee review and has not been enacted.